Treatment of red degeneration of fibroid in pregnancy:
**Question:** Treatment of red degeneration of fibroid in pregnancy:
A. Oral contraceptives
B. Hysterectomy
C. Gonadotropin-releasing hormone (GnRH) agonists
D. Medical termination of pregnancy (MTOP)
**Correct Answer:** C. Gonadotropin-releasing hormone (GnRH) agonists
**Core Concept:** Red degeneration of fibroid is a rare complication of pregnancy characterized by rapid growth and increased vascularity of uterine fibroids. This can cause significant maternal and fetal complications. The correct management depends on the stage of pregnancy and the severity of the condition.
**Why the Correct Answer is Right:** Gonadotropin-releasing hormone (GnRH) agonists are the first-line treatment option for red degeneration of uterine fibroids in pregnancy. These drugs act on the hypothalamus to suppress gonadotropin secretion, leading to a decrease in uterine fibroid size and a reduction in blood flow. This helps to prevent maternal and fetal complications associated with the condition.
**Why Each Wrong Option is Incorrect:**
A. Oral contraceptives are not recommended for pregnant women and can lead to severe complications.
B. Hysterectomy is a major surgery with significant risks to the pregnant woman and fetus.
D. Medical termination of pregnancy (MTOP) is not a suitable option for treating red degeneration of uterine fibroids as the primary goal is to manage the fibroid rather than terminate the pregnancy.
**Why MTOP is Incorrect:**
Medical termination of pregnancy (MTOP) is a method used to end an established pregnancy. In this case, the primary goal is to manage the red degeneration of uterine fibroids, not terminate the pregnancy. Thus, MTOP is not a suitable option for treating red degeneration of uterine fibroids.
**Core Concept:** Red degeneration of uterine fibroids is a clinical condition that occurs during pregnancy, and the correct management depends on the stage of pregnancy and the severity of the condition.
**Why GnRH Agonists are Right:** Gonadotropin-releasing hormone (GnRH) agonists work by suppressing gonadotropin secretion, leading to a decline in uterine fibroid size and a decrease in blood flow within the fibroids. This approach helps to prevent maternal and fetal complications associated with red degeneration of uterine fibroids.
**Why Other Options are Incorrect:**
A. Oral contraceptives are contraindicated in pregnant women and can lead to severe complications.
B. Hysterectomy is a major surgical procedure with significant risks to the pregnant woman and fetus.
**Why Hysterectomy is Incorrect:** Hysterectomy is a major surgical procedure that involves the removal of the uterus. In the context of red degeneration of uterine fibroids, the primary goal is to manage the red degeneration of uterine fibroids, not to perform a hysterectomy. Therefore, hysterectomy is not a suitable option